These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 1862314
1. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin]. Brocard JJ, Keller U, Oberhänsli A, Riesen WF. Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314 [Abstract] [Full Text] [Related]
2. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia]. Darioli R, Bovet P, Brunner HR, Bercher L. Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221 [Abstract] [Full Text] [Related]
4. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL. Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606 [Abstract] [Full Text] [Related]
5. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study]. Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A. Minerva Cardioangiol; 1993 Mar 15; 41(3):105-9. PubMed ID: 8510811 [Abstract] [Full Text] [Related]
6. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease. French JK, White HD, Greaves SC. N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688 [Abstract] [Full Text] [Related]
7. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F. Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363 [Abstract] [Full Text] [Related]
8. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G. Can J Cardiol; 1993 Jun 02; 9(5):405-12. PubMed ID: 8348392 [Abstract] [Full Text] [Related]
9. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug]. Mol MJ, Stuyt PM, Stalenhoef AF. Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555 [Abstract] [Full Text] [Related]
10. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. Geisel J, Oette K, Burrichter H. Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032 [Abstract] [Full Text] [Related]
11. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]. Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L. Cardiologia; 1990 Apr 10; 35(4):335-40. PubMed ID: 2245435 [Abstract] [Full Text] [Related]
12. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V, Harvengt C. Int J Clin Pharmacol Ther Toxicol; 1989 Feb 10; 27(2):76-81. PubMed ID: 2921098 [Abstract] [Full Text] [Related]
13. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia. O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D. Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801 [Abstract] [Full Text] [Related]
14. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis]. Giannini SD, de Góes JM, Dereviack BE, Machado C, Forti N, Diament J. Arq Bras Cardiol; 1990 Jun 07; 54(6):407-14. PubMed ID: 2288531 [Abstract] [Full Text] [Related]
15. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia]. Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P. Cardiologia; 1993 Dec 07; 38(12):773-8. PubMed ID: 8200011 [Abstract] [Full Text] [Related]
16. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR. Arch Intern Med; 1990 Feb 07; 150(2):341-5. PubMed ID: 2405804 [Abstract] [Full Text] [Related]
17. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)]. Golay A, Lehmann T, James R, Pometta D. Schweiz Med Wochenschr; 1993 Aug 21; 123(33):1553-8. PubMed ID: 8372340 [Abstract] [Full Text] [Related]
18. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study]. Pernigotti L, Bo M, Poli L, Zanocchi M, Fiandra U, Pedrazzini V, Fabris F. Recenti Prog Med; 1991 Mar 21; 82(3):155-62. PubMed ID: 2047557 [Abstract] [Full Text] [Related]
19. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group. J Womens Health (Larchmt); 2004 Dec 21; 13(10):1101-7. PubMed ID: 15650343 [Abstract] [Full Text] [Related]
20. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin. Maher VM, Thompson GR. Q J Med; 1990 Feb 21; 74(274):165-75. PubMed ID: 2111917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]